Contingent Consideration - Schedule of Commercialization Payments (Parentheticals) (Details) - Upon total worldwide Net Sales of all Licensed Products exceeding [Member] |
12 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
| |
| Contingent Consideration - Schedule of Commercialization Payments (Parentheticals) (Details) [Line Items] | |
| Net sales of all licensed products exceeding value | $ 250,000,000 |
| Net sales of all licensed products exceeding value | 500,000,000 |
| Net sales of all licensed products exceeding value | $ 1,000,000,000 |